ICD10 code of Fabry disease and ICD9 code

Fabry disease is classified under the ICD-10-CM code E75.21 (Fabry-Anderson disease) and was previously identified by the ICD-9-CM code 272.7. These codes are essential for medical billing, insurance authorization, and clinical documentation for patients managing the multisystemic effects of this condition.

What is the clinical significance of Fabry disease coding?

Because Fabry disease is a rare, multisystemic lysosomal storage disorder, accurate coding is vital for coordinating multidisciplinary care. The ICD-10 code E75.21 specifically identifies the deficiency of the enzyme alpha-galactosidase A, which leads to the systemic accumulation of globotriaosylceramide (Gb3) in the vascular endothelium, kidneys, heart, and nervous system. For the 174 members of the DiseaseMaps community living with Fabry disease, these codes often serve as the gateway to accessing specialized treatments like enzyme replacement therapy (ERT) or chaperone therapy.

How is Fabry disease diagnosed and documented?

Diagnosis of Fabry disease typically begins with clinical suspicion of symptoms such as acroparesthesia (burning pain in hands and feet), hypohidrosis (reduced sweating), and angiokeratomas (small, dark skin spots). Confirmation is achieved through biochemical testing (measuring alpha-galactosidase A activity) and genetic testing to identify mutations in the GLA gene. Once diagnosed, physicians use the ICD-10 code E75.21 to ensure that the patient’s electronic health record clearly reflects the systemic nature of the disease, which is critical for tracking long-term complications like hypertrophic cardiomyopathy or chronic kidney disease.

Is Fabry disease hereditary and how is it passed down?

Fabry disease follows an X-linked inheritance pattern, meaning the causative gene is located on the X chromosome. This inheritance pattern is crucial for genetic counseling, as it explains why the disease affects both males and females, though symptoms in females can be highly variable due to X-inactivation. Understanding the genetic basis of Fabry disease allows families to seek cascade testing for at-risk relatives. Genetic counselors often utilize the diagnostic codes to justify the medical necessity of testing family members who may be asymptomatic carriers.

What are the common clinical manifestations tracked under these codes?

When clinicians document Fabry disease, they are often monitoring for specific organ-system involvement. The following list highlights the primary areas that physicians track using the diagnostic framework associated with E75.21:

• Cardiac: Left ventricular hypertrophy, arrhythmias, and potential heart failure.


• Renal: Progressive proteinuria and declining glomerular filtration rate (GFR).


• Neurological: Increased risk of transient ischemic attacks (TIA) and strokes at a younger age.


• Dermatological: Characteristic angiokeratomas and reduced ability to regulate body temperature.


• Gastrointestinal: Chronic pain and bowel habit changes associated with autonomic nervous system involvement.

Next steps

• Consult with a metabolic geneticist or a cardiologist specializing in lysosomal storage disorders to discuss your specific clinical profile.


• Ensure your specialist uses the correct ICD-10 code (E75.21) when submitting paperwork to insurance to ensure coverage for specialized therapies.


• Connect with the 174 other members on DiseaseMaps.org who are navigating the same diagnostic and treatment journey for Fabry disease.


• Request a referral for genetic counseling if you have family members who have not yet been screened for the GLA mutation.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center: Fabry Disease.


• Orphanet: Fabry Disease (ORPHA:324).


• Online Mendelian Inheritance in Man (OMIM): #301500 (Fabry Disease).


• National Fabry Disease Foundation: Clinical resources and patient support guidelines.